No Data
Shineway Pharmaceutical's 2024 Profit Slides 13%; Shares Fall 8%
Hong Kong stocks moving | SHINEWAY PHARM (02877) fell over 7% in the afternoon, with last year's revenue and net profit both showing double-digit declines.
SHINEWAY PHARM (02877) fell over 7% in the afternoon, as of the time of writing, down 7.63%, reported at HKD 8.11, with a transaction volume of HKD 15.5962 million.
SHINEWAY PHARM announced its annual performance, with a profit of 0.84 billion yuan for the year, a year-on-year decrease of 13.35%.
SHINEWAY PHARM (02877) announced its annual performance for 2024, with an operating revenue of 3.778 billion yuan (RMB, the same below), a year-on-year decrease of 16.35%; annual profit of 0.84 billion yuan, a year-on-year decrease of 13.35%; basic earnings per share of 111 cents; a proposed first interim dividend of 36 cents per share. The announcement stated that in 2024, the group's overall operating revenue significantly decreased, mainly due to the high baseline effect from the previous year's surge in demand for respiratory, cold, and anti-infection pharmaceuticals, along with multiple factors such as changes in market demand due to the macro economy and policy adjustments, leading to a decline in overall sales.
Express News | China Shineway Pharmaceutical - to Declare First Interim Dividend for 2025 of RMB36 Cents per Share
Express News | China Shineway Pharmaceutical Group FY Sales RMB 3,780 Million
Express News | China Shineway Pharmaceutical Group FY Gross Margin 75%
China Shineway Pharmaceutical Group Limited's (HKG:2877) 30% Share Price Surge Not Quite Adding Up
